Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

How is Brexit affecting pharmacists' future planning?

The results of a C+D straw poll on the predicted impact of the UK’s exit from the EU are now in.

C+D readers remain cautious about the future as the dust settles on the UK’s decision to leave the EU, according to results of a straw poll.

When asked how Brexit is affecting their future planning, more than half (52%) of respondents to a C+D online poll said they were "waiting to see what happens" when formal negotiations over the UK’s exit from the EU begin.

Of the 123 respondents to the poll – which ran on the C+D website between July 11-19 – 12% have already started to make changes in their pharmacies, (see graph), while the remaining 36% do not expect Brexit to impact their pharmacy at all.

When questioned before the referendum vote, 40% of C+D readers said they would be voting to stay, compared to 39% who would opt to leave. 

"Now is the time for a robust plan"

The reality of this, and the long-term ramifications of Brexit are yet to be understood, Numark managing director John D’Arcy told C+D last week, but now is the time to act, he said. “We need to face up to life outside of the EU and put a robust plan of action in place," he added.

The National Pharmacy Association is hoping that the current confusion and uncertainty over Brexit might cause the Department of Health to “reconsider” its plans to cut pharmacy funding in England by £170 million in October.

How will Brexit affect your pharmacy?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008244

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel